Macy's Inc. raised its fiscal 2026 net sales outlook to $21.5-$21.75 billion from $21.4-$21.65 billion, while comparable sales guidance increased to 0.5-1.2% from a decline of 0.5% to growth of 0.5%. The adjusted EPS guidance rose to $2-$2.20 from $1.90-$2.10. The company is gaining momentum in its luxury business as part of its Bold New Chapter strategy, with Bloomingdale's and Bluemercury emerging as important contributors to growth plans. Bloomingdale's is expanding its luxury assortment with brands like Chloe Ready-to-Wear, Isabel Marant, Phoebe Philo, Park Denim, Aireloom and Kate Shoes, while Bluemercury is benefiting from demand across makeup, dermatological skin care and fragrances, with brands such as Byredo, Parfums de Marly, Dr. Diamond's Metacine and SkinCeuticals enhancing its premium assortment. Macy's shares have risen 73.5% over the past year compared with the industry's 34.9% growth, and the stock currently has a Zacks Rank #2 (Buy).
Macy’s IncMacy's raised its fiscal 2026 sales and EPS guidance, citing luxury banner momentum.
Kohl's Corporation
Ross Stores Inc
Target Corporation